TY - JOUR
T1 - Lipid signalling drives proteolytic rewiring of mitochondria by YME1L
AU - MacVicar, Thomas
AU - Ohba, Yohsuke
AU - Nolte, Hendrik
AU - Mayer, Fiona Carola
AU - Tatsuta, Takashi
AU - Sprenger, Hans Georg
AU - Lindner, Barbara
AU - Zhao, Yue
AU - Li, Jiahui
AU - Bruns, Christiane
AU - Krüger, Marcus
AU - Habich, Markus
AU - Riemer, Jan
AU - Schwarzer, Robin
AU - Pasparakis, Manolis
AU - Henschke, Sinika
AU - Brüning, Jens C.
AU - Zamboni, Nicola
AU - Langer, Thomas
N1 - Funding Information:
Acknowledgements We thank D. Ehrentraut for expert technical assistance; L. Raatz and M. Heitmann for assisting with xenograft analysis and tissue protein extraction; and A. Wilbrand-Hennes and U. Cullmann of the CECAD proteomics facility for technical assistance. RNA sequencing was performed at the Cologne Center for Genomics and Data Analysis in the MPI Biology of Ageing bioinformatics core facility. We thank J. Altmüller, M. Franitza, F. Metge and J. Boucas for technical and bioinformatic assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (La918/15-1; SFB1218/A1), the German-Israel-Project (DIP; RA1028/10-1) and the Max-Planck-Society to T.L.; EMBO and Alexander von Humboldt fellowships to T.M. (GA-2013-609409, ALTF 1220-2014); and a fellowship of the Japan Society for the Promotion of Science (JSPS) for research abroad, The Osamu Hayaishi Memorial Scholarship for Study Abroad and grants from the Uehara Memorial Foundation to Y.O. We are grateful for the following gifts: Tsc2−/− MEFs from C. Demetriades and D. Kwiatkowski, Atg5−/− MEFs from K. Winklhofer, WT (S/S) and EIF2αS51A knock-in MEFs from R. Kaufman, 4E-BP DKO, iRaptor and iRictor MEFs from H. McBride and pUC57-LbNOX from V. Mootha (Addgene plasmid # 75285).
Publisher Copyright:
© 2019, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2019/11/14
Y1 - 2019/11/14
N2 - Reprogramming of mitochondria provides cells with the metabolic flexibility required to adapt to various developmental transitions such as stem cell activation or immune cell reprogramming, and to respond to environmental challenges such as those encountered under hypoxic conditions or during tumorigenesis1–3. Here we show that the i-AAA protease YME1L rewires the proteome of pre-existing mitochondria in response to hypoxia or nutrient starvation. Inhibition of mTORC1 induces a lipid signalling cascade via the phosphatidic acid phosphatase LIPIN1, which decreases phosphatidylethanolamine levels in mitochondrial membranes and promotes proteolysis. YME1L degrades mitochondrial protein translocases, lipid transfer proteins and metabolic enzymes to acutely limit mitochondrial biogenesis and support cell growth. YME1L-mediated mitochondrial reshaping supports the growth of pancreatic ductal adenocarcinoma (PDAC) cells as spheroids or xenografts. Similar changes to the mitochondrial proteome occur in the tumour tissues of patients with PDAC, suggesting that YME1L is relevant to the pathophysiology of these tumours. Our results identify the mTORC1–LIPIN1–YME1L axis as a post-translational regulator of mitochondrial proteostasis at the interface between metabolism and mitochondrial dynamics.
AB - Reprogramming of mitochondria provides cells with the metabolic flexibility required to adapt to various developmental transitions such as stem cell activation or immune cell reprogramming, and to respond to environmental challenges such as those encountered under hypoxic conditions or during tumorigenesis1–3. Here we show that the i-AAA protease YME1L rewires the proteome of pre-existing mitochondria in response to hypoxia or nutrient starvation. Inhibition of mTORC1 induces a lipid signalling cascade via the phosphatidic acid phosphatase LIPIN1, which decreases phosphatidylethanolamine levels in mitochondrial membranes and promotes proteolysis. YME1L degrades mitochondrial protein translocases, lipid transfer proteins and metabolic enzymes to acutely limit mitochondrial biogenesis and support cell growth. YME1L-mediated mitochondrial reshaping supports the growth of pancreatic ductal adenocarcinoma (PDAC) cells as spheroids or xenografts. Similar changes to the mitochondrial proteome occur in the tumour tissues of patients with PDAC, suggesting that YME1L is relevant to the pathophysiology of these tumours. Our results identify the mTORC1–LIPIN1–YME1L axis as a post-translational regulator of mitochondrial proteostasis at the interface between metabolism and mitochondrial dynamics.
UR - http://www.scopus.com/inward/record.url?scp=85074795588&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074795588&partnerID=8YFLogxK
U2 - 10.1038/s41586-019-1738-6
DO - 10.1038/s41586-019-1738-6
M3 - Article
C2 - 31695197
AN - SCOPUS:85074795588
SN - 0028-0836
VL - 575
SP - 361
EP - 365
JO - Nature
JF - Nature
IS - 7782
ER -